Cargando…

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction

BACKGROUND: Despite lipid-lowering and antiplatelet therapy, the pattern of residual lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to evaluate the effects of combined therapies, commonly used in subjects with acute myocardial infarction, in the quality of low-dens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lotfollahi, Zahra, Mello, Ana P. Q., Fonseca, Francisco A. H., Machado, Luciene O., Mathias, Andressa F., Izar, Maria C., Damasceno, Nagila R. T., Oliveira, Cristiano L. P., Neto, Antônio M. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426937/ https://www.ncbi.nlm.nih.gov/pubmed/36040917 http://dx.doi.org/10.1371/journal.pone.0273292

Ejemplares similares

Green-banana biomass consumption by diabetic patients improves plasma low-density lipoprotein particle functionality
por: Lotfollahi, Zahra, et al.
Publicado: (2020)

Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction
por: Pinto, Leticia C. S., et al.
Publicado: (2021)

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2 )(Lp-PLA(2 )): a review
por: Silva, Isis T, et al.
Publicado: (2011)

Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
por: Cartolano, Flávia De C., et al.
Publicado: (2017)

Role of Inflammation in Cardiac Remodeling After Acute Myocardial Infarction
por: Fonseca, Francisco A., et al.
Publicado: (2022)

Is Lipid Accumulation Product Associated with an Atherogenic Lipoprotein Profile in Brazilian Subjects?
por: Cartolano, Flavia De Conti, et al.
Publicado: (2018)

Significance of antiplatelet therapy in emergency myocardial infarction treatment
por: Komosa, Anna, et al.
Publicado: (2014)

Oxidized and electronegative low-density lipoprotein as potential biomarkers of cardiovascular risk in obese adolescents
por: de Freitas, Maria Camila Pruper, et al.
Publicado: (2018)

Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in adolescents: the healthy young cross-sectional study
por: da Silva, Isis T, et al.
Publicado: (2013)

Low High-Density Lipoprotein and Risk of Myocardial Infarction
por: Ramirez, A., et al.
Publicado: (2015)

Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial
por: Fonseca, Francisco A. H., et al.
Publicado: (2017)

Evaluation of two highly effective lipid-lowering therapies in subjects with acute myocardial infarction
por: Klassen, Aline, et al.
Publicado: (2021)

Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy
por: Camargo, L.M., et al.
Publicado: (2014)

Rare Presentation of Dercum’s Disease in a Child with Abnormalities in Lipoprotein Metabolism
por: Izar, Maria Cristina de Oliveira, et al.
Publicado: (2018)

Omega-3 Fatty Acids Improve Functionality of High-Density Lipoprotein in Individuals With High Cardiovascular Risk: A Randomized, Parallel, Controlled and Double-Blind Clinical Trial
por: Cartolano, Flávia De Conti, et al.
Publicado: (2022)

Potential of lipoproteins as biomarkers in acute myocardial infarction
por: Khan, Haseeb Ahmad, et al.
Publicado: (2017)

Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
por: Weiss, Thomas W., et al.
Publicado: (2016)

Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
por: Lin, Ting-Tse, et al.
Publicado: (2018)

Serum lipoprotein levels in takotsubo cardiomyopathy vs. myocardial infarction
por: Gaddam, Sainath, et al.
Publicado: (2011)

Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
por: Holmes, Michael V., et al.
Publicado: (2018)

Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience
por: Rakowski, Tomasz, et al.
Publicado: (2013)

Dual antiplatelet therapy in a patient with simultaneous aneurysmal subarachnoid hemorrhage and myocardial infarction
por: Mortazavi, Abolghasem, et al.
Publicado: (2020)

Causal Relationship of Coronary Artery Calcium on Myocardial Infarction and Preventive Effect of Antiplatelet Therapy
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Role of B lymphocytes in the infarcted mass in patients with acute myocardial infarction
por: Casarotti, Ana C.A., et al.
Publicado: (2021)

Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy
por: Reid, Christopher, et al.
Publicado: (2020)

Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?
por: Fonseca, Marília Izar Helfenstein, et al.
Publicado: (2017)

Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice
por: He, Hongliang, et al.
Publicado: (2020)

Lipoprotein (a) and myocardial infarction: impact on long-term mortality
por: Zhang, Jian, et al.
Publicado: (2023)

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study
por: Adamski, Piotr, et al.
Publicado: (2017)

Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
por: Handoyo, Victoria, et al.
Publicado: (2019)

Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease
por: Rymer, Jennifer A., et al.
Publicado: (2019)

The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy
por: Simek, Stanislav, et al.
Publicado: (2020)

Impact of preprocedural coronary flow grade on duration of dual antiplatelet therapy in acute myocardial infarction
por: Kim, Yong Hoon, et al.
Publicado: (2021)

Antiplatelet therapy in patients with myocardial infarction with non-obstructive coronary arteries: A clinical perspective
por: Chen, Wenjie, et al.
Publicado: (2023)

Omega-3 Fatty Acids in Erythrocyte Membranes as Predictors of Lower Cardiovascular Risk in Adults without Previous Cardiovascular Events
por: Gonçalinho, Gustavo Henrique Ferreira, et al.
Publicado: (2021)

Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies
por: Kasmas, S.H., et al.
Publicado: (2012)

Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry
por: Tang, Xiaofang, et al.
Publicado: (2021)

Dual Antiplatelet Therapy and the Severity Risk of Lower Intestinal Bleeding
por: Carlin, Neal, et al.
Publicado: (2017)

Early Dual-Antiplatelet Therapy at the Emergency Department Is Associated with Lower In-Hospital Major Adverse Cardiac Event Risk among Patients with Non-ST-Elevation Myocardial Infarction
por: Yang, Jen-Han, et al.
Publicado: (2021)

Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review
por: Nascimento, Bruno Ramos, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oai52as23fe279fgqpfo013ema